New insights into the role of VIP on the ratio of T-cell subsets during the development of autoimmune diabetes.
Jimeno
Rebeca
R
Departamento de Biología Celular, Facultad de Biología, Universidad Complutense de Madrid, Madrid, Spain.
Gomariz
Rosa P
RP
Gutiérrez-Cañas
Irene
I
Martínez
Carmen
C
Juarranz
Yasmina
Y
Leceta
Javier
J
D000818:Animals; D015551:Autoimmunity / Q000276:immunology*; D049109:Cell Proliferation; D016207:Cytokines / Q000032:analysis / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology* / Q000517:prevention & control / Q000628:therapy; D005260:Female; D051858:Forkhead Transcription Factors / Q000378:metabolism; D006801:Humans; D051379:Mice; D016688:Mice, Inbred NOD; D057132:Nuclear Receptor Subfamily 1, Group F, Member 3 / Q000378:metabolism; D010179:Pancreas / Q000378:metabolism; D013154:Spleen / Q000166:cytology; D050378:T-Lymphocytes, Regulatory / Q000166:cytology / Q000378:metabolism; D018417:Th1 Cells / Q000166:cytology / Q000378:metabolism; D058504:Th17 Cells / Q000166:cytology / Q000378:metabolism; D018418:Th2 Cells / Q000166:cytology / Q000378:metabolism; D014660:Vasoactive Intestinal Peptide / Q000502:physiology* / Q000627:therapeutic use*
D016207:Cytokines; D051858:Forkhead Transcription Factors; C498833:Foxp3 protein, mouse; D057132:Nuclear Receptor Subfamily 1, Group F, Member 3; D014660:Vasoactive Intestinal Peptide